Understanding artemisinin-resistant malaria
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical)
Reference49 articles.
1. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial
2. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
3. The Threat of Artemisinin-Resistant Malaria
4. The Mechanisms of Parasite Clearance after Antimalarial Treatment ofPlasmodium falciparumMalaria
5. Ex vivo perfusion of human spleens maintains clearing and processing functions
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of the binding interactions between Plasmodium falciparum Kelch-13 mutant recombinant proteins with artemisinin;PLOS ONE;2024-08-15
2. An overview of artemisinin-resistant malaria and associated Pfk13 gene mutations in Central Africa;Parasitology Research;2024-07
3. Revealing the artemisinin and piperaquine treatment failure: a systematic review;Bali Medical Journal;2023-01-18
4. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India;Malaria Journal;2022-12-24
5. Fitness costs and benefits in response to artificial artesunate selection in Plasmodium;Peer Community Journal;2022-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3